Product Information

SERTRALINE 150 MG CAPSULE is a generic product labeled by Alvogen Inc., priced at $1.3829 per EA under NDC 47781095130. Its NADAC has been published 43 times since Oct 29, 2025.

FDA first approved this application on Oct 4, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SERTRALINE 150 MG CAPSULE

sertraline hydrochloride
$1.3829per EA

Strength

150 mg/1

Manufacturer

Alvogen Inc.

NDC

47781095130

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

SERTRALINE HYDROCHLORIDE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA215133

FDA Approved

10/4/2021

TE Code

AB

On Market Since

9/18/2025

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for SERTRALINE 150 MG CAPSULE has been published 43 times since Oct 29, 2025, and over the history we have for it it has declined 73.3%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3829 per EA
All-time high$5.1702 (Nov 12, 2025)
All-time low$1.3829 (Aug 19, 2026)
52-week high$5.1702
52-week low$1.3829
Median price$4.7220
Average price$4.1197
Largest weekly change-33.8% (Jul 22, 2026)
Weeks tracked43
Tracking sinceOct 29, 2025

Price History

1W

-18.7%

1M

-46.1%

3M

-61.1%

6M

-71.3%

1Y

N/A

3Y

N/A

5Y

N/A

All

-73.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of SERTRALINE 150 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE 150 MG CAPSULE, manufactured by Alvogen Inc., is $1.3829 per EA (NDC 47781095130), effective Aug 19, 2026.

How has the price of SERTRALINE 150 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for SERTRALINE 150 MG CAPSULE has declined 73.3%. It has been tracked across 43 weekly CMS publications since Oct 29, 2025.

What are the highest and lowest recorded NADAC prices for SERTRALINE 150 MG CAPSULE?

Since Oct 29, 2025, the NADAC for SERTRALINE 150 MG CAPSULE has ranged from a low of $1.3829 (Aug 19, 2026) to a high of $5.1702 (Nov 12, 2025), with a median of $4.7220 per EA.

Are there cheaper alternatives to SERTRALINE 150 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SERTRALINE 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures SERTRALINE 150 MG CAPSULE?

SERTRALINE 150 MG CAPSULE (NDC 47781095130) is labeled by Alvogen Inc., and CMS classifies it as a generic product.